Trial intelligence / Profile preview

Takepron (lansoprazole) special drug use surveillance in GERD with dyspepsia symptoms

jRCT1080222261

Sponsor
Takeda
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of lansoprazole in gastroesophageal reflux disease (GERD), erosive esophagitis (EE), Non-erosive Gastroesophageal Reflux Disease (NERD) and 1 more, sponsored by Takeda.

02

Drugs

lansoprazole
03

Conditions

gastroesophageal reflux disease (GERD)erosive esophagitis (EE)Non-erosive Gastroesophageal Reflux Disease (NERD)functional dyspepsia (FD)

Beyond the preview

Go deeper on jRCT1080222261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call